Origin and significance of urinary N-acetyl-β,D-glucosaminidase (NAG) in renal patients with proteinuria

Clinica Chimica Acta

Volumn 255, Issue 2, 1996, Pages 133-144

  Costigan, Michael G ^a   Rustom, Rana ^a   Bone, J Michael ^a   Shenkin, Alan ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

D glucosaminidase; N acetyl ; Plasma and kidney NAG isoenzymes; Proteinuria; Renal failure; Tubular injury; Urinary

Indexed keywords

ISOENZYME; N ACETYL BETA GLUCOSAMINIDASE;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FAST PROTEIN LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY PARENCHYMA; KIDNEY TUBULE NECROSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEINURIA; URINALYSIS;

EID: 0030606323     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06400-5     Document Type: Article

References (24)

1. [1] Jones AP, Lock S, Griffiths KD. Urinary N-acetyl-β,D-glucosaminidase activity in type I diabetes mellitus. Ann Clin Biochem 1995;32(1):58-62.
2. [2] Agardh CD, Agardh E, Isaksson A, Hultberg B. Association between urinary N-acetyl-β,D-glucosaminidase and its isoenzyme patterns and microangiopathy in type I diabetes mellitus. Clin Chem 1991;37:1696-1699.
3. [3] Sri Krishna K, Kirubakaran MG, Pandey AP, Kanagasabapathy AS. Urinary N-acetyl-β,D-glucosaminidase and aminopeptidase N in the diagnosis of graft rejection after live donor renal transplantation. Clin Chim Acta 1985;150:69-85.
4. [4] Price RG. The role of NAG (N-acetyl-β,D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 1992;38(Suppl 1):S14-S19.
5. [5] Ellis BG, Tucker SM, Thompson AE, Price RG. Presence of serum and tissue forms of N-acetyl-β,D-glucosaminidase in urine from patients with renal disease. Clin Chim Acta 1975;64:195-202.
6. [6] Ikonne JV, Ellis RB. N-acetyl-β,D-hexosaminidase component A. Different forms in human tissues and fluids. Biochem J 1973;135:457-462.
7. [7] Shibasaki T, Gomi H, Ishimoto F, Miyahara T. Urinary N-acetyl-acetyl-β,D-glucosaminidase isoenzyme activity as measured by fast protein liquid chromatography in patients with nephrotic syndrome. Clin Chem 1990;36(1):102-103.
8. [8] Williams PS, Fass G, Bone JM. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med 1988;67(252):343-354.
9. [9] Rustom R, Jackson MJ, Critchley M, Bone JM. Tubular metabolism of Aprotinin 99mTc and urinary ammonia: effects of Proteinuria. J Min Electrol Metab 1992;18(2-5):108-112.
10. [10] Maruhn D. Rapid colorimetric assay of galactosidase and N-acetyl-β,D-glucosaminidase in human urine. Clin Chim Acta 1976;73:453-461.
11. [11] Watanabe N, Kamel S, Ohkubo A, Yamanaka M, Ohsawa S, Makino K, Tokuda K. Urinary protein as measured with pyrogallol red-molybdate complex. Manually and in a Hitachi 726 automated analyser. Clin Chem 1986;32:1551.
12. [12] Bohle A, Mackensen-Haen S, Von Gise H et al. The consequences of tubulo-interstitial changes for renal function in glomerulopathies. Pathol Res Pract 1990;186:135-144.
13. [13] El Nahas AM. Mechanism of progression and consequences of nephron reduction. In: Cameron S, Davison A, Grunfeld J-P, Kerr D, Ritz E, eds. Oxford Textbook of Clinical Nephrology. Oxford: Oxford University Press, 1992;191-1227.
14. [14] Jung K. Urinary enzymes and low molecular weight proteins as markers of tubular dysfunction. Kid Int Suppl 1994;47:S29-S33.
15. [15] Bernard AM, Vyskocil AA, Mahieu P, Lauwerys RR. Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin Chem 1987;33(6):775-779.
16. [16] Piscator M. Early detection of tubular dysfunction. Kid Int (Suppl) 1991;34:S15-S17.
17. [17] Beukes HAG, Oosthuizen MMJ, Lambrechts H, Myburgh JA. Litthauer D, Naude RJ. Properties of the isoenzyme forms A1, A2 and B of N-acetyl-β,D-glucosaminidase purified from baboon kidneys. Int J Biochem 1991;23:239-251.
18. [18] Hultberg B. Urinary excretion of β-hexosaminidase in different forms of proteinuria. Clin Chim Acta 1980;108:195-199.
19. [19] Tsau YK, Chen CH, Yang LF, Sheu JN. Urinary acetyl-beta-glucosaminidase in children with idiopathic nephrotic syndrome. Acta Paediatr Sin 1991;32(5):286-290.
20. [20] Ring E, Zobel G, Erwa W, Haim-Kutting M. Urinary excretion of N-acetyl-β,D-glucosaminidase in proteinuric states. Child Nephrol Urol 1992;12:15-18
21. [21] Kunin CM, Chesney RW, Craig WA, England AC, DeAnglis C. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-β,D-glucosaminidase in general population and in patients with renal disease. Paediatrics 1978;62:751-762.
22. [22] Williams JD, Coles GA. Proteinuria - a direct cause of renal morbidity?. Kid Int 1994;45:443-450.
23. [23] Kaysen GA, Hutchison FN, Bander ALH. The effect of the nephrotic syndrome on the renal handling of protein and other nutrients. Semin Nephrology 1990;10(5):481-490.
24. [24] Harris DCH, Chan L, Schrier RW. Remnant kidney hypermetabolism and progression of chronic renal failure. Am J Physiol 1988;254:F267-F276.